- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x 3SZ: 3-{[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl}aniline(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
FBP.2: 18 residues within 4Å:- Chain A: L.450, T.451, K.452, S.453, R.455, S.456, W.501, R.508, T.532, G.533, W.534, R.535, P.536, G.537, S.538, G.539, F.540, T.541
15 PLIP interactions:15 interactions with chain A- Hydrogen bonds: A:K.452, A:S.453, A:S.456, A:S.456, A:G.533, A:R.535, A:G.537, A:S.538, A:G.539, A:F.540
- Water bridges: A:D.504, A:D.504, A:R.508
- Salt bridges: A:K.452, A:R.508
FBP.18: 17 residues within 4Å:- Chain B: L.450, T.451, K.452, S.453, R.455, S.456, W.501, R.508, G.533, R.535, P.536, G.537, S.538, G.539, F.540, T.541
- Ligands: UNX.22
18 PLIP interactions:18 interactions with chain B- Hydrogen bonds: B:K.452, B:S.453, B:G.454, B:S.456, B:S.456, B:G.533, B:R.535, B:G.537, B:S.538, B:G.539, B:F.540
- Water bridges: B:R.455, B:R.455, B:R.474, B:R.508, B:R.508
- Salt bridges: B:K.452, B:R.508
FBP.30: 17 residues within 4Å:- Chain C: L.450, T.451, K.452, S.453, R.455, S.456, W.501, R.508, T.532, G.533, R.535, P.536, G.537, S.538, G.539, F.540, T.541
17 PLIP interactions:17 interactions with chain C- Hydrogen bonds: C:T.451, C:K.452, C:S.453, C:S.456, C:S.456, C:G.533, C:G.537, C:S.538, C:G.539, C:F.540, C:T.541
- Water bridges: C:R.508, C:R.508, C:R.508, C:T.541
- Salt bridges: C:K.452, C:R.508
FBP.44: 17 residues within 4Å:- Chain D: L.450, T.451, K.452, S.453, R.455, S.456, W.501, R.508, G.533, W.534, R.535, P.536, G.537, S.538, G.539, F.540, T.541
18 PLIP interactions:18 interactions with chain D- Hydrogen bonds: D:T.451, D:K.452, D:S.453, D:R.455, D:S.456, D:S.456, D:S.456, D:G.533, D:R.535, D:G.537, D:S.538, D:G.539, D:F.540
- Water bridges: D:R.508, D:R.508, D:T.541
- Salt bridges: D:K.452, D:R.508
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: S.96, H.97, G.98, K.225
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:G.98
- Salt bridges: A:H.97
SO4.19: 6 residues within 4Å:- Chain B: R.92, N.94, S.96, D.132, K.289
- Ligands: UNX.21
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:N.94, B:S.96
- Water bridges: B:R.92
- Salt bridges: B:R.92, B:K.289
SO4.31: 2 residues within 4Å:- Chain C: V.497, E.499
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:E.499
SO4.45: 6 residues within 4Å:- Chain D: R.92, N.94, S.96, D.132, K.289
- Ligands: UNX.50
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.94, D:S.96
- Salt bridges: D:R.92, D:K.289
- 42 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.4: 3 residues within 4Å:- Chain A: R.62, G.87, H.398
Ligand excluded by PLIPUNX.5: 9 residues within 4Å:- Chain A: N.94, S.96, D.132, T.133, S.262, K.289
- Ligands: UNX.8, UNX.9, UNX.10
Ligand excluded by PLIPUNX.6: 7 residues within 4Å:- Chain A: S.262, F.263, K.289, E.291, D.315
- Ligands: UNX.10, UNX.13
Ligand excluded by PLIPUNX.7: 6 residues within 4Å:- Chain A: E.291, A.312, G.314, D.315, T.347
- Ligands: UNX.13
Ligand excluded by PLIPUNX.8: 6 residues within 4Å:- Chain A: R.92, N.94, K.289
- Ligands: UNX.5, UNX.9, UNX.13
Ligand excluded by PLIPUNX.9: 6 residues within 4Å:- Chain A: N.94, S.96, E.137, R.139
- Ligands: UNX.5, UNX.8
Ligand excluded by PLIPUNX.10: 8 residues within 4Å:- Chain A: S.96, T.133, K.134, E.137, S.262, F.263
- Ligands: UNX.5, UNX.6
Ligand excluded by PLIPUNX.11: 1 residues within 4Å:- Chain A: R.297
Ligand excluded by PLIPUNX.12: 1 residues within 4Å:- Chain A: D.255
Ligand excluded by PLIPUNX.13: 6 residues within 4Å:- Chain A: K.289, E.291, A.312
- Ligands: UNX.6, UNX.7, UNX.8
Ligand excluded by PLIPUNX.14: 4 residues within 4Å:- Chain A: E.82, K.85, S.86, R.395
Ligand excluded by PLIPUNX.15: 3 residues within 4Å:- Chain A: I.245, K.249, V.276
Ligand excluded by PLIPUNX.16: 2 residues within 4Å:- Chain A: R.111, Q.254
Ligand excluded by PLIPUNX.17: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.20: 1 residues within 4Å:- Chain B: R.111
Ligand excluded by PLIPUNX.21: 7 residues within 4Å:- Chain B: N.94, S.96, D.132, T.133, S.262, K.289
- Ligands: SO4.19
Ligand excluded by PLIPUNX.22: 6 residues within 4Å:- Chain B: T.428, S.456, G.539, F.540, T.541
- Ligands: FBP.18
Ligand excluded by PLIPUNX.23: 5 residues within 4Å:- Chain A: T.360, A.362
- Chain B: Q.348, E.351, E.363
Ligand excluded by PLIPUNX.24: 6 residues within 4Å:- Chain B: C.336, N.337, K.341, V.343, D.376, R.464
Ligand excluded by PLIPUNX.25: 3 residues within 4Å:- Chain B: A.104, K.108, Q.254
Ligand excluded by PLIPUNX.26: 4 residues within 4Å:- Chain A: T.360
- Chain B: E.351, S.352, E.363
Ligand excluded by PLIPUNX.27: 2 residues within 4Å:- Chain B: R.274, K.282
Ligand excluded by PLIPUNX.28: 2 residues within 4Å:- Chain B: T.99, H.100
Ligand excluded by PLIPUNX.29: 5 residues within 4Å:- Chain B: F.95, S.96, H.97, G.98, K.243
Ligand excluded by PLIPUNX.32: 8 residues within 4Å:- Chain C: N.94, S.96, D.132, T.133, S.262, K.289
- Ligands: UNX.33, UNX.36
Ligand excluded by PLIPUNX.33: 9 residues within 4Å:- Chain C: S.96, T.133, K.134, E.137, S.262, F.263
- Ligands: UNX.32, UNX.34, UNX.36
Ligand excluded by PLIPUNX.34: 7 residues within 4Å:- Chain C: S.262, F.263, K.289, E.291, D.315
- Ligands: UNX.33, UNX.36
Ligand excluded by PLIPUNX.35: 4 residues within 4Å:- Chain C: A.312, R.313, G.314, T.347
Ligand excluded by PLIPUNX.36: 5 residues within 4Å:- Chain C: R.92, K.289
- Ligands: UNX.32, UNX.33, UNX.34
Ligand excluded by PLIPUNX.37: 1 residues within 4Å:- Chain C: R.139
Ligand excluded by PLIPUNX.38: 5 residues within 4Å:- Chain C: G.147, T.148, A.149, G.223, S.224
Ligand excluded by PLIPUNX.39: 5 residues within 4Å:- Chain C: N.63, H.483, Y.485, G.487, I.488
Ligand excluded by PLIPUNX.40: 1 residues within 4Å:- Chain C: H.100
Ligand excluded by PLIPUNX.41: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPUNX.42: 4 residues within 4Å:- Chain C: L.230, A.233, V.235, E.319
Ligand excluded by PLIPUNX.46: 4 residues within 4Å:- Chain D: R.111, Q.254
- Ligands: UNX.47, UNX.49
Ligand excluded by PLIPUNX.47: 6 residues within 4Å:- Chain D: I.107, R.111, Q.254
- Ligands: UNX.46, UNX.49, UNX.51
Ligand excluded by PLIPUNX.48: 2 residues within 4Å:- Ligands: UNX.49, UNX.51
Ligand excluded by PLIPUNX.49: 4 residues within 4Å:- Chain D: R.111
- Ligands: UNX.46, UNX.47, UNX.48
Ligand excluded by PLIPUNX.50: 7 residues within 4Å:- Chain D: N.94, S.96, D.132, T.133, S.262, K.289
- Ligands: SO4.45
Ligand excluded by PLIPUNX.51: 3 residues within 4Å:- Chain D: K.108
- Ligands: UNX.47, UNX.48
Ligand excluded by PLIPUNX.52: 5 residues within 4Å:- Chain D: A.312, R.313, G.314, A.346, T.347
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anastasiou, D. et al., Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat.Chem.Biol. (2012)
- Release Date
- 2010-04-28
- Peptides
- Pyruvate kinase isozymes M1/M2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.95 Å
- Oligo State
- homo-tetramer
- Ligands
- 2 x 3SZ: 3-{[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl}aniline(Non-covalent)
- 4 x FBP: 1,6-di-O-phosphono-beta-D-fructofuranose(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 42 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anastasiou, D. et al., Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat.Chem.Biol. (2012)
- Release Date
- 2010-04-28
- Peptides
- Pyruvate kinase isozymes M1/M2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D